(Q46155242)

20 December 2017

title

Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial (English)

1 reference

20 December 2017

1 reference

1

Markolf Hanefeld

1 reference

20 December 2017

Avraham Karasik

2

1 reference

20 December 2017

Carsta Koehler

series ordinal

3

1 reference

20 December 2017

Torsten Westermeier

series ordinal

4

1 reference

20 December 2017

Jean-Louis Chiasson

series ordinal

5

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

20 December 2017

Diabetes and Vascular Disease Research

published in

1 reference

20 December 2017

volume

6

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

32-37

1 reference

20 December 2017

Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Using metabolic syndrome traits for efficient detection of impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

(How) can we prevent type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2009.006

21 January 2018

Identifiers

DOI

10.3132/DVDR.2009.006

1 reference

20 December 2017

1 reference

20 December 2017